Covishield is currently in phase 2 and phase 3 human trials. (Figurative) New Delhi: The Union Ministry of Health has said it disagrees with the Rs 80 billion figure cited by Adar Poonawalla, CEO of the Serum Institute of India, the world’s largest vaccine manufacturer by volume, and that it …
Read More »
PUNE: The Phase III human clinical trial of the Covid-19 vaccine being developed by the University of Oxford and manufactured by the Serum Institute of India (SII), began at the state-run Sassoon General Hospital here in Maharashtra On Monday, a senior official said. “We have started phase III trials of …
Read More »
A day after the Serum Institute of India (SII) received a demonstration cause notice from the Controller General of Drugs of India (DCGI), it said it was pausing trials of the Covid-19 vaccine in the country. IBS is manufacturing the Covishield vaccine at the University of Oxford in collaboration with …
Read More »
NEW DELHI: In another grim milestone, the number of active cases in the country surpassed 8 lakh, having risen from the 7 lakh mark in 11 days. It had taken 15 days for active cases to increase from 6 lakh to 7 lakh. There has been a sudden increase in …
Read More »